Adamax (1032 Grade) 10mg

Important dilution note: Cloudiness after dilution is most commonly associated with non-pharmaceutical-grade dilution solution. Cloudy product concerns are not eligible for refund unless Pfizer pharmaceutical-grade dilution solution was used.

Vial Size: 3ml

Grade: 1032 (refers to the ~1032 g/mol molecular-weight form; see Molecular Weight below)

Form: Lyophilized white to off-white powder

CAS Number: None consistently assigned — Adamax has no widely recognized CAS registry number in authoritative chemical databases; it is a proprietary/vendor-designated research peptide rather than a pharmacopeial compound. Some third-party listings display placeholder or unverified CAS values; treat these with caution.

Chemical Name: Adamax — described in vendor literature as an acetylated, C-terminally modified analogue of Semax, applying the N-terminal and C-terminal modifications associated with Peptide 021 (P021). Note: although the “Adam-” name and some listings invoke an adamantane modification, the structure commonly circulated for Adamax (below) is an N-acetylated, C-terminally amidated/extended Semax analogue; whether a literal adamantane group is present is not consistently documented across sources.

Synonyms: N-Acetyl-Semax-Adamantane; Ac-Semax analogue; Adamax peptide

Sequence: Ac-Met-Glu-His-Phe-Pro-Gly-Pro-Ala-Gly-NH₂ (amide) or -OH (free acid), depending on supplier — commonly written Ac-MEHFPGPAG. A 9-residue N-acetylated analogue built on the ACTH(4-7) core (Met-Glu-His-Phe) shared with Semax, extended by Pro-Gly-Pro.

Molecular Formula: C50H69N11O11S (the ~1032 g/mol form most commonly listed for Adamax). The N-acetyl free-acid form (Ac-MEHFPGPAG-OH) is instead reported as C44H61N11O13S (~984 g/mol). Values differ across vendors depending on the C-terminus (amide vs. free acid) and reported modifications — treat as approximate pending your own analytical confirmation.

Molecular Weight: ~1032.2 g/mol (C50H69N11O11S). Free-acid listings report ~984.1 g/mol. No independently established, pharmacopeial value exists.

Purity: ≥98% (HPLC) — see batch COA

Storage Conditions: Store at 2–8°C for short-term (days–weeks) or −20°C for long-term storage, desiccated and protected from light

Solubility: Soluble in DMSO; some vendor documentation reports aqueous solubility for reconstitution (bacteriostatic water), consistent with Semax-class peptides

Receptor Activity: Described in preclinical/research-vendor literature as a Semax analogue investigated for BDNF upregulation and hippocampal TrkB receptor sensitivity; the terminal modifications are proposed to increase resistance to enzymatic degradation and enhance blood-brain-barrier penetration relative to unmodified Semax. Note: unlike Semax (a well-characterized ACTH fragment with published pharmacology), Adamax’s mechanism of action is not established in peer-reviewed literature — claims originate from vendor and nootropics-community sources rather than controlled clinical studies.

Regulatory Note: Adamax has been identified as a designer peptide in New Zealand and suggested for prescription-medicine classification there — worth knowing if you’re evaluating sourcing or regulatory status.

Certificate of Analysis: Available for all batches (verify with individual supplier).

For research and laboratory use only. Not for human or animal consumption. This product has not been evaluated by the FDA and is not intended to diagnose, treat, cure, or prevent any disease or condition. For use by qualified research professionals only.

Important dilution note: Cloudiness after dilution is most commonly associated with non-pharmaceutical-grade dilution solution. Cloudy product concerns are not eligible for refund unless Pfizer pharmaceutical-grade dilution solution was used.

Vial Size: 3ml

Grade: 1032 (refers to the ~1032 g/mol molecular-weight form; see Molecular Weight below)

Form: Lyophilized white to off-white powder

CAS Number: None consistently assigned — Adamax has no widely recognized CAS registry number in authoritative chemical databases; it is a proprietary/vendor-designated research peptide rather than a pharmacopeial compound. Some third-party listings display placeholder or unverified CAS values; treat these with caution.

Chemical Name: Adamax — described in vendor literature as an acetylated, C-terminally modified analogue of Semax, applying the N-terminal and C-terminal modifications associated with Peptide 021 (P021). Note: although the “Adam-” name and some listings invoke an adamantane modification, the structure commonly circulated for Adamax (below) is an N-acetylated, C-terminally amidated/extended Semax analogue; whether a literal adamantane group is present is not consistently documented across sources.

Synonyms: N-Acetyl-Semax-Adamantane; Ac-Semax analogue; Adamax peptide

Sequence: Ac-Met-Glu-His-Phe-Pro-Gly-Pro-Ala-Gly-NH₂ (amide) or -OH (free acid), depending on supplier — commonly written Ac-MEHFPGPAG. A 9-residue N-acetylated analogue built on the ACTH(4-7) core (Met-Glu-His-Phe) shared with Semax, extended by Pro-Gly-Pro.

Molecular Formula: C50H69N11O11S (the ~1032 g/mol form most commonly listed for Adamax). The N-acetyl free-acid form (Ac-MEHFPGPAG-OH) is instead reported as C44H61N11O13S (~984 g/mol). Values differ across vendors depending on the C-terminus (amide vs. free acid) and reported modifications — treat as approximate pending your own analytical confirmation.

Molecular Weight: ~1032.2 g/mol (C50H69N11O11S). Free-acid listings report ~984.1 g/mol. No independently established, pharmacopeial value exists.

Purity: ≥98% (HPLC) — see batch COA

Storage Conditions: Store at 2–8°C for short-term (days–weeks) or −20°C for long-term storage, desiccated and protected from light

Solubility: Soluble in DMSO; some vendor documentation reports aqueous solubility for reconstitution (bacteriostatic water), consistent with Semax-class peptides

Receptor Activity: Described in preclinical/research-vendor literature as a Semax analogue investigated for BDNF upregulation and hippocampal TrkB receptor sensitivity; the terminal modifications are proposed to increase resistance to enzymatic degradation and enhance blood-brain-barrier penetration relative to unmodified Semax. Note: unlike Semax (a well-characterized ACTH fragment with published pharmacology), Adamax’s mechanism of action is not established in peer-reviewed literature — claims originate from vendor and nootropics-community sources rather than controlled clinical studies.

Regulatory Note: Adamax has been identified as a designer peptide in New Zealand and suggested for prescription-medicine classification there — worth knowing if you’re evaluating sourcing or regulatory status.

Certificate of Analysis: Available for all batches (verify with individual supplier).

For research and laboratory use only. Not for human or animal consumption. This product has not been evaluated by the FDA and is not intended to diagnose, treat, cure, or prevent any disease or condition. For use by qualified research professionals only.